TrialSleep2020

Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2.

Mikko Kärppä et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.